I have been on about 100 mg of
EffexorEffexor
Effexor xr for about 2 months now. Prior to that I had been on
ProzacProzac
Prozac weekly for some time. I also take 50 mg of Trazadone at bedtime and 1 mg of
KlonopinKlonopin
Klonopin wafer at bedtime. I have noticed for the past few weeks that I have been severely EXHAUSTED for the past 2 1/2 weeks even though I get sufficient
sleep and don't seem terribly depressed. I feel it as a real physical exhaustion. My PCP did the usual battery of tests and the only the he came up with is slightly low testosterone (I am a 42 year old
femaleCondoms
Female condoms
Female sexual dysfunction).
I'm wondering if what I could be experiencing is the "Seretonin Syndrome". THE
SEROTONINSerum serotonin level SYNDROME:
"The
serotoninSerum serotonin level syndrome is a hypersotonergic state which is a very dangerous and a potentially fatal side effect of serotonergic enhancing drugs which can have multiple psychiatric and non-psychiatric symptoms."
Can you let me know if this may be a possibility ? Thanks.
http://www.antidepressantsfacts.com/micromedex-serotonin-syndrome.htm
but, i have no idea if this is what your going through...
Serotonin syndrome induced by low-dose venlafaxine.
Pan JJ, Shen WW.
Department of Psychiatry, Taipei Medical University-Wan Fang Hospital, Taipei, Taiwan.
OBJECTIVE: To report the case of a patient with serotonin syndrome induced by low-dose venlafaxine. CASE SUMMARY: A 29-year-old Taiwanese woman with major depressive disorder abruptly developed serotonin syndrome during low-dose (37.5 mg/d) venlafaxine monotherapy, with symptoms of restlessness, tremor, shivering, diarrhea, vomiting, ataxia, tachycardia, and myoclonus. The patient recovered in 2 hours after receiving prochlorperazine and lorazepam in the emergency department. Venlafaxine was discontinued, and she was discharged home. Two weeks later, the patient started to receive fluoxetine 20 mg/d and reported no adverse adverse effects during follow-up clinic visits. DISCUSSION: The clinical manifestations of this case meet Sternbach's criteria of serotonin syndrome. Its possible etiologic factors include panic attack, adverse drug reaction, pharmacodynamic interaction, and congenital absence of CYP2D6 enzyme activity. The Naranjo probability scale suggested a probable causality of venlafaxine treatment and serotonin syndrome. CONCLUSIONS: Clinicians should be aware of the risk of serotonin syndrome when the patient receives not only a combination of 2 antidepressants, but also the single potent serotonergic agent venlafaxine.